Identifying SAEs poses several challenges. One of the primary issues is the underreporting of adverse events, which can lead to an incomplete safety profile of a medical product. Additionally, distinguishing between an adverse event caused by the medical product and those arising from other medical conditions or treatments can be complex. Causality assessment methods such as the Naranjo Algorithm are often used but are not foolproof.
